Cell Lysis And Fractionation Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Cell Lysis And Fractionation Industry In 2025?

The cell lysis and fractionation market has experienced robust expansion in its size over recent years. Projections indicate it will expand from $3.42 billion in 2024 to reach $3.69 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.9%. Historically, this expansion has been driven by factors such as increased investments in life science research, an intensified focus on personalized medicine, the high incidence of various diseases, innovations in cell lysis and fractionation techniques, and an increasing need for biopharmaceuticals and biotechnology products.

Projections indicate robust expansion for the cell lysis and fractionation market, with its valuation reaching $4.83 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth during the forecast period is driven by several factors, including an intensified focus on personalized medicine, increased governmental investment in research, a significant need for efficient cell lysis and fractionation techniques, ongoing technological progress within genomics and proteomics, and the increasing incidence of chronic and infectious ailments. Key trends anticipated over the forecast period encompass the sustained uptake of personalized medicine strategies, greater incorporation of automation and robotics into lysis and fractionation procedures, broadening applications in clinical diagnostics and pharmaceutical development, innovations in microfluidics and lab-on-a-chip technologies for cellular analysis, and a heightened emphasis on point-of-care and decentralized testing options.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

What Are The Key Drivers Of Growth In The Cell Lysis And Fractionation Market?

The future expansion of the cell lysis and fractionation markets is anticipated due to an increasing emphasis on personalized medicine. This developing medical approach utilizes an individual’s genetic profile for disease diagnosis and treatment, involving the tailoring of medical decisions and interventions to each patient’s unique characteristics, particularly their genetic makeup. Cell lysis and fractionation are crucial in precision medicine, as they facilitate the separation and analysis of specific subcellular elements like proteins, organelles, and nucleic acids from patient samples. This enables scientists and medical professionals to investigate the molecular processes underlying illness and formulate customized treatments based on each patient’s distinct molecular traits. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines were available on the market for people with multiple types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. Consequently, the growing focus on personalized medicine is driving the growth of the cell lysis and fractionation markets.

What Are The Key Segments In The Cell Lysis And Fractionation Market?

The cell lysis and fractionationmarket covered in this report is segmented –

1) By Type: Mammalian Cells; Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation; Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes; Biopharmaceutical; Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells; Suspension Mammalian Cells; Primary Cells; Cell Lines

2) By Microbial Cells: Bacterial Cells; Yeast Cells; Fungal Cells; Algal Cells

How Are Trends Influencing The Cell Lysis And Fractionation Market?

Leading companies operating in the cell lysis and fractionation market are concentrating on introducing advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain a competitive edge. These lysis kits offer a simplified AAV (Adeno-associated virus) lysis methodology that will improve SOPs (Standard Operating Procedures), quality control, and safety while standardizing bioprocessing workflows. For instance, in July 2023, QIAGEN, a Germany-based provider of sample and assay technologies, launched the new CGT Viral Vector Lysis Kit. This kit makes it possible to quantify virus titers for several serotypes with an exact and uniform procedure starting with cell lysates. The new CGT viral vector lysis kit complements QIAGEN’s rapidly expanding digital PCR portfolio for the biopharma industry, which already includes three QIAcuity Residual DNA Quantification Kits to check for host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for use in adeno-associated virus (AAV) titer quantification.

Which Leading Players Are Enhancing Their Cell Lysis And Fractionation Market Presence Worldwide?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Which Geographies Are Emerging As Strong Markets For The Cell Lysis And Fractionation Industry?

North America was the largest region in the cell lysis and fractionation market in 2024. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell Lysis And Fractionation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp

Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2025, By The Business Research Company

Aircraft Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aircraft-pumps-global-market-report

Cell Counting Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report

Cellular M2M Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellular-m2m-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795